Stock DNA
Pharmaceuticals & Biotechnology
JPY 7,095,302 Million (Large Cap)
28.00
NA
0.00%
-0.51
21.73%
7.26
Total Returns (Price + Dividend) 
HOYA Corp. for the last several years.
Risk Adjusted Returns v/s 
News

HOYA Corp. Stock Hits Day High with Strong 3.55% Intraday Surge
HOYA Corp. has experienced notable gains today, reaching an intraday high and showing a strong weekly and monthly performance compared to the Japan Nikkei 225. The company maintains solid financial health with a high return on equity and consistent positive results, although its annual performance has lagged behind the market.
Read More
HOYA Corp. Hits Day High with Strong 5.87% Intraday Surge
HOYA Corp., a key player in the Pharmaceuticals & Biotechnology sector, has seen significant gains recently, outperforming the Japan Nikkei 225. The company boasts a solid financial foundation, with a strong Return on Equity and consistent positive results over the past five quarters, indicating robust operational performance.
Read More
HOYA Corp. Stock Hits Day Low Amid Price Pressure, Closes at JPY 21,040.00
HOYA Corp., a key player in the Pharmaceuticals & Biotechnology sector, saw its stock decline significantly on October 14, 2025. Despite recent challenges, the company maintains strong long-term fundamentals, including a solid return on equity and consistent positive results over the past five quarters, while navigating a competitive market.
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Foreign Institutions
Held in 0 Schemes (0%)
Held by 3 Foreign Institutions (0.06%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is 1.68% vs -1.85% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is 0.68% vs 0.62% in Mar 2025
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 13.56% vs 5.39% in Mar 2024
YoY Growth in year ended Mar 2025 is 10.51% vs 8.16% in Mar 2024






